Mohamed Gaballah
Giza, GZ, Egypt
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Genetic Characterization and Pathogenesis of Highly Pathogenic Avian Influenza Virus A (H5N1) Isolated in Egypt During 2021-2023.
Journal: Viruses
Published: September 12, 2025
Antiviral activity of Hellenia speciosa (J. Koenig) S.R. Dutta rhizome metabolites against human adenovirus: insights from molecular docking and in vitro studies.
Journal: Frontiers in pharmacology
Published: August 18, 2025
Antiviral potential of Melissa officinalis extracts against influenza and emerging coronaviruses.
Journal: Scientific reports
Published: February 18, 2025
Emergence of a novel reassortant highly pathogenic avian influenza clade 2.3.4.4b A(H5N2) Virus, 2024.
Journal: Emerging microbes & infections
Published: January 27, 2025
Highly pathogenic avian influenza virus H5N1 clade 2.3.4.4b in wild rats in Egypt during 2023.
Journal: Emerging microbes & infections
Published: August 28, 2024
Genetic and pathogenic potential of highly pathogenic avian influenza H5N8 viruses from live bird markets in Egypt in avian and mammalian models.
Journal: PloS one
Published: June 26, 2024
Diverse bioactive secondary metabolites from Aspergillus terreus: antimicrobial, anticancer, and anti-SARS-CoV-2 activity studies.
Journal: Zeitschrift fur Naturforschung. C, Journal of biosciences
Published: April 09, 2024
Potent Antiviral Activity of Vitamin B12 against Severe Acute Respiratory Syndrome Coronavirus 2, Middle East Respiratory Syndrome Coronavirus, and Human Coronavirus 229E.
Journal: Microorganisms
Published: September 26, 2023
Corrigendum to "Quercitrin loaded cyclodextrin based nanosponge as a promising approach for management of lung cancer and COVID-19" [J. Drug Deliv. Sci. Technol. 77 (2022) 103921].
Journal: Journal of drug delivery science and technology
Published: June 12, 2023
Last Updated: 09/26/2026